The BEST-CLI trial is nearing the finish line and promises to be worth the wait
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Surgery
Reference32 articles.
1. Peripheral artery disease: epidemiology and global perspectives;Fowkes;Nat Rev Cardiol,2017
2. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population;Nehler;J Vasc Surg,2014
3. Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft;Sachs;J Vasc Surg,2011
4. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States;Mahoney;Circ Cardiovasc Qual Outcomes,2010
5. The current state of critical limb ischemia: a systematic review;Farber;JAMA Surg,2016
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Common Criticisms and Rebuttals of the Best Endovascular Versus Best Surgical Therapy in Patients with Chronic Limb-Threatening Ischemia (BEST-CLI) Trial;Annals of Vascular Surgery;2024-10
2. Surgical and Endovascular Therapies for Below-the-Knee Peripheral Arterial Disease: A Contemporary Review;Journal of the Society for Cardiovascular Angiography & Interventions;2024-03
3. Treatment Variability Among Patients Hospitalized for Chronic Limb‐Threatening Ischemia: An Analysis of the 2016 to 2018 US National Inpatient Sample;Journal of the American Heart Association;2024-02-06
4. Technical Success, Midterm Primary Patency, and Factors Affecting Primary Patency of Subintimal Angioplasty Followed by Vasculomimetic Stenting for Trans-Atlantic Intersociety Consensus II C and D Femoropopliteal Arterial Disease—A Prospective Study;Indian Journal of Radiology and Imaging;2023-12-04
5. A systematic review and meta-analysis of primary bypass surgery compared with bypass surgery after endovascular treatment in peripheral artery disease patients;Journal of Vascular Surgery;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3